
Full profile: /officials/W000795
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-07-22
Source: Congress.gov
Currently in
The federal government would test a program that rewards health insurance plans financially when they successfully prevent kidney disease patients from reaching end-stage renal disease, which requires dialysis or transplants. Plans that invest in preventive care and achieve better outcomes would share in the savings generated by avoiding expensive end-stage treatments. This demonstration would help determine whether giving insurers financial incentives to focus on kidney disease prevention could improve patient health while reducing overall healthcare costs.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.